진단용 특수 항체 시장 : 제품 유형별, 용도별, 최종 사용자별, 국가별, 지역별 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

REPORT HIGHLIGHT

Diagnostic Specialty Antibodies Market size was valued at USD 27,910 Million in 2023, expanding at a CAGR of 5.23% from 2024 to 2032.

Diagnostic specialty antibodies are a type of antibodies that have been specifically designed and are used for diagnostic purposes in different medical and scientific fields. These antibodies are highly precise in targeting their intended molecules, which allows for accurate detection and measurement. They typically recognize unique epitopes on the molecules they are targeting, ensuring that there is minimal interference from other substances. Diagnostic antibodies find applications in various diagnostic techniques such as enzyme-linked immunosorbent assay (ELISA), immunohistochemistry (IHC), western blotting, flow cytometry, and immunofluorescence. By helping to identify and quantify specific analytes in biological samples, these antibodies play a crucial role in the diagnosis and monitoring of diseases.

Diagnostic Specialty Antibodies Market- Market Dynamics

Rise in occurrence of Infectious and chronic diseases are expected to propel the growth of market

Chronic illnesses like cancer, cardiovascular diseases, diabetes, and autoimmune disorders are increasing in prevalence. Diagnostic specialty antibodies are essential for precise diagnosis and monitoring of these conditions. The Centers for Disease Control reports that chronic diseases contribute to approximately 75 percent of healthcare expenses in the United States, amounting to an estimated USD5300 per person per year. Additionally, as healthcare infrastructure improves and healthcare spending rises in emerging markets, there is considerable opportunity for the global expansion of the diagnostic specialty antibodies market. Nevertheless, the high costs associated with the development and validation of these antibodies may hinder market growth.

Diagnostic Specialty Antibodies Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.23% over the forecast period (2024-2032)

Based on product type segmentation, Monoclonal Antibodies was predicted to show maximum market share in the year 2023

Based on application segmentation, Infectious Disease Diagnostics was the leading type in 2023

Based on End User segmentation, Hospitals was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Diagnostic Specialty Antibodies Market- Segmentation Analysis:

The Global Diagnostic Specialty Antibodies Market is segmented on the basis of Product Type, Application, End-User, and Region.

The market is segmented into three categories according to product type: Monoclonal Antibodies, Polyclonal Antibodies, and Recombinant Polyclonal Antibodies. Monoclonal Antibodies hold the largest share in the market. Monoclonal antibodies are essential in the diagnostic specialty antibodies market, providing exceptional specificity and reproducibility for a wide range of diagnostic purposes.

The market is categorized into six segments based on application: Hepatitis Diagnostics, Tuberculosis Diagnostics, Dengue Diagnostics, Oncology Diagnostics, HIV Diagnostics, Infectious Disease Diagnostics, and Others. Infectious Disease Diagnostics holds the largest share in the market. The global market for diagnostic specialty antibodies is witnessing continuous growth, driven by the rising prevalence of infectious diseases, the rising need for quick and precise diagnostic tests, and advancements in antibody technology.

The market is segmented into two categories according to End-User: Diagnostic Laboratories, Hospitals, Others. Hospitals are the dominant force in the market. With hospitals increasingly embracing cutting-edge diagnostic technologies and personalized medicine strategies, the need for diagnostic specialty antibodies is projected to rise, fueling progress and breakthroughs in healthcare diagnostics.

Diagnostic Specialty Antibodies Market- Geographical Insights

Geographically, this market spans across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented by countries contributing to business activities. The market is predominantly led by North America, attributed to its well-established healthcare infrastructure. The region boasts one of the highest healthcare expenditure levels globally, with substantial investments from governments, private insurers, and individuals in healthcare services and products. In 2022, U.S. health care spending increased by 4.1 percent, totaling USD4.5 trillion or USD13,493 per capita. Health spending in the U.S. accounted for 17.3 percent of the nation's Gross Domestic Product, as reported by the National Health Expenditure Accounts (NHEA). Following North America, Europe emerges as the second-largest region for market growth during the forecast period, driven by the rising popularity of self-testing kits and the growing number of regulatory approvals for test kits targeting infectious diseases.

Diagnostic Specialty Antibodies Market- Competitive Landscape:

In the market for custom antibody development and production services, companies strive to stand out by offering personalized solutions to diagnostic assay developers and researchers. These solutions encompass various aspects such as antibody design, production, purification, conjugation, and validation. Providers distinguish themselves through their technical expertise, stringent quality assurance measures, and exceptional customer support. The market is further fueled by the presence of innovative startups and biotechnology firms that continuously introduce novel antibody technologies and diagnostic assays. These companies may specialize in niche markets, address emerging diagnostic needs, or possess proprietary antibody platforms. Startups often gain a competitive edge by offering disruptive technologies, maintaining rapid innovation cycles, and adopting flexible business models.

Recent Developments:

On April 17, 2020, Roche announced the development and forthcoming release of its Elecsys Anti-SARS-CoV-2 serology test designed to identify antibodies in individuals who have been exposed to the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) responsible for causing the COVID-19 illness.

The FDA has issued two emergency use authorizations (EUAs) to Abbott this week, permitting diagnostic and antibody tests to be conducted on the company's Alinity systems. Nowadays, the agency granted authorization for Abbott's COVID-19 molecular diagnostic test to be used on its new Alinity m molecular laboratory instrument. Abbott has initiated the rollout of the Alinity m system to customers in the United States.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL Diagnostic Specialty Antibodies MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

F. Hoffmann- La Roche AG

Abcam PLC

Abbott Laboratories

Bio-Rad Laboratories Inc.

Agilent Technologies Inc.

Creative Diagnostics

Thermo Fisher Scientific Inc.

Becton, Dickinson and Company

Merck KGaA

Sartorius AG

Others

GLOBAL DIAGNOSTIC SPECIALTY ANTIBODIES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

• Monoclonal Antibodies
• Polyclonal Antibodies
• Recombinant Polyclonal Antibodies

GLOBAL DIAGNOSTIC SPECIALTY ANTIBODIES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Hepatitis Diagnostics
• Tuberculosis Dignostics
• Dengue DiaGnostic
• Oncology Diagnostic
• HIV Diagnostic
• Infectious Disease Diagnostics
• Others

GLOBAL DIAGNOSTIC SPECIALTY ANTIBODIES MARKET, BY End-User- MARKET ANALYSIS, 2019 - 2032

• Diagnostic Laboratories
• Hospitals*
• Others

GLOBAL DIAGNOSTIC SPECIALTY ANTIBODIES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• The U.S.
• Canada
• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe
• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1.Diagnostic Specialty Antibodies Market Overview

• 1.1.Study Scope
• 1.2.Market Estimation Years

2.Executive Summary

• 2.1.Market Snippet
  • 2.1.1.Diagnostic Specialty Antibodies Market Snippet by Product Type
  • 2.1.2.Diagnostic Specialty Antibodies Market Snippet by Application
  • 2.1.3.Diagnostic Specialty Antibodies Market Snippet by End-User
  • 2.1.4.Diagnostic Specialty Antibodies Market Snippet by Country
  • 2.1.5.Diagnostic Specialty Antibodies Market Snippet by Region
• 2.2.Competitive Insights

3.Diagnostic Specialty Antibodies Key Market Trends

• 3.1.Diagnostic Specialty Antibodies Market Drivers
  • 3.1.1.Impact Analysis of Market Drivers
• 3.2.Diagnostic Specialty Antibodies Market Restraints
  • 3.2.1.Impact Analysis of Market Restraints
• 3.3.Diagnostic Specialty Antibodies Market Opportunities
• 3.4.Diagnostic Specialty Antibodies Market Future Trends

4.Diagnostic Specialty Antibodies Industry Study

• 4.1.PEST Analysis
• 4.2.Porter's Five Forces Analysis
• 4.3.Growth Prospect Mapping
• 4.4.Regulatory Framework Analysis

5.Diagnostic Specialty Antibodies Market: COVID-19 Impact Analysis

• 5.1.Pre-COVID-19 Impact Analysis
• 5.2.Post-COVID-19 Impact Analysis
  • 5.2.1.Top Performing Segments
  • 5.2.2.Marginal Growth Segments
  • 5.2.3.Top Looser Segments
  • 5.2.4.Marginal Loss Segments

6.Diagnostic Specialty Antibodies Market Landscape

• 6.1.Diagnostic Specialty Antibodies Market Share Analysis, 2023
• 6.2.Breakdown Data, by Key Manufacturer
  • 6.2.1.Established Players' Analysis
  • 6.2.2.Emerging Players' Analysis

7.Diagnostic Specialty Antibodies Market - By Product Type

• 7.1.Overview
  • 7.1.1.Segment Share Analysis, By Product Type, 2023 & 2032 (%)
  • 7.1.2.Monoclonal Antibodies
  • 7.1.3.Polyclonal Antibodies
  • 7.1.4.Recombinant Polyclonal Antibodies

8.Diagnostic Specialty Antibodies Market - By Application

• 8.1.Overview
  • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
  • 8.1.2.Hepatitis Diagnostics
  • 8.1.3.Tuberculosis Dignostics
  • 8.1.4.Dengue DiaGnostic
  • 8.1.5.Oncology Diagnostic
  • 8.1.6.HIV Diagnostic
  • 8.1.7.Infectious Disease Diagnostics
  • 8.1.8.Others

9.Diagnostic Specialty Antibodies Market - By End-User

• 9.1.Overview
  • 9.1.1.Segment Share Analysis, By End-User, 2023 & 2032 (%)
  • 9.1.2.Diagnostic Laboratories
  • 9.1.3.Hospitals*
  • 9.1.4.Others

10.Diagnostic Specialty Antibodies Market- By Geography

• 10.1.Introduction
  • 10.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
• 10.2.North America
  • 10.2.1.Overview
  • 10.2.2.Diagnostic Specialty Antibodies Key Manufacturers in North America
  • 10.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.2.4.North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 10.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.2.6.North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.2.7.U.S.
    • 10.2.7.1.Overview
    • 10.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.7.3.U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.7.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7.5.U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.2.8.Canada
    • 10.2.8.1.Overview
    • 10.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.2.8.3.Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.8.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8.5.Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 10.3.Europe
  • 10.3.1.Overview
  • 10.3.2.Diagnostic Specialty Antibodies Key Manufacturers in Europe
  • 10.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.3.4.Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 10.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3.6.Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.7.Germany
    • 10.3.7.1.Overview
    • 10.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.7.3.Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.7.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7.5.Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.8.Italy
    • 10.3.8.1.Overview
    • 10.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.8.3.Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.8.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8.5.Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.9.United Kingdom
    • 10.3.9.1.Overview
    • 10.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.9.3.United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.9.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9.5.United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.10.France
    • 10.3.10.1.Overview
    • 10.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.10.3.France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.10.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10.5.France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.11.Russia
    • 10.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.11.2.Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.11.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11.4.Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.12.Netherlands
    • 10.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.12.2.Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.12.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12.4.Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.13.Sweden
    • 10.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.13.2.Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.13.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13.4.Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.14.Poland
    • 10.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.14.2.Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.14.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14.4.Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3.15.Rest of Europe
    • 10.3.15.1.Overview
    • 10.3.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.3.15.3.Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.15.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15.5.Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 10.4.Asia Pacific (APAC)
  • 10.4.1.Overview
  • 10.4.2.Diagnostic Specialty Antibodies Key Manufacturers in Asia Pacific
  • 10.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.4.4.Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 10.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4.6.Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.7.India
    • 10.4.7.1.Overview
    • 10.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.7.3.India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.7.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7.5.India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.8.China
    • 10.4.8.1.Overview
    • 10.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.8.3.China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.8.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8.5.China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.9.Japan
    • 10.4.9.1.Overview
    • 10.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.9.3.Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.9.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9.5.Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.10.South Korea
    • 10.4.10.1.Overview
    • 10.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.10.3.South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.10.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10.5.South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.11.Australia
    • 10.4.11.1.Overview
    • 10.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.11.3.Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.11.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11.5.Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.12.Thailand
    • 10.4.12.1.Overview
    • 10.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.12.3.Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.12.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12.5.Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.13.Indonesia
    • 10.4.13.1.Overview
    • 10.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.13.3.Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.13.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13.5.Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.14.Philippines
    • 10.4.14.1.Overview
    • 10.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.14.3.Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.14.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14.5.Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4.15.Rest of APAC
    • 10.4.15.1.Overview
    • 10.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.4.15.3.Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.15.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15.5.Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 10.5.Latin America
  • 10.5.1.Overview
  • 10.5.2.Diagnostic Specialty Antibodies Key Manufacturers in Latin America
  • 10.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.5.4.Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 10.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5.6.Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.7.Brazil
    • 10.5.7.1.Overview
    • 10.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.7.3.Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.7.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7.5.Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.8.Mexico
    • 10.5.8.1.Overview
    • 10.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.8.3.Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.8.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8.5.Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.9.Argentina
    • 10.5.9.1.Overview
    • 10.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.9.3.Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.9.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9.5.Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.10.Colombia
    • 10.5.10.1.Overview
    • 10.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.10.3.Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.10.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10.5.Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5.11.Rest of LATAM
    • 10.5.11.1.Overview
    • 10.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.5.11.3.Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.11.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11.5.Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
• 10.6.Middle East and Africa
  • 10.6.1.Overview
  • 10.6.2.Diagnostic Specialty Antibodies Key Manufacturers in Middle East and Africa
  • 10.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 10.6.4.Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  • 10.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6.6.Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.7.Saudi Arabia
    • 10.6.7.1.Overview
    • 10.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.7.3.Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.7.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7.5.Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.8.United Arab Emirates
    • 10.6.8.1.Overview
    • 10.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.8.3.United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.8.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8.5.United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.9.Israel
    • 10.6.9.1.Overview
    • 10.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.9.3.Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.9.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9.5.Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.10.Turkey
    • 10.6.10.1.Overview
    • 10.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.10.3.Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.10.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10.5.Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.11.Algeria
    • 10.6.11.1.Overview
    • 10.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.11.3.Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.11.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11.5.Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.12.Egypt
    • 10.6.12.1.Overview
    • 10.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.12.3.Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.12.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12.5.Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6.13.Rest of MEA
    • 10.6.13.1.Overview
    • 10.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 10.6.13.3.Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.13.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13.5.Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11.Key Vendor Analysis- Diagnostic Specialty Antibodies Industry

• 11.1.Competitive Dashboard
• 11.2.Company Profiles
  • 11.2.1.F. Hoffmann- La Roche AG
  • 11.2.2.Abcam PLC
  • 11.2.3.Abbott Laboratories
  • 11.2.4.Bio-Rad Laboratories Inc.
  • 11.2.5.Agilent Technologies Inc.
  • 11.2.6.Creative Diagnostics
  • 11.2.7.Thermo Fisher Scientific Inc.
  • 11.2.8.Becton, Dickinson and Company
  • 11.2.9.Merck KGaA
  • 11.2.10.Sartorius AG
  • 11.2.11.Others

12.360 Degree Analyst View

13.Appendix

• 13.1.Research Methodology
• 13.2.References
• 13.3.Abbreviations
• 13.4.Disclaimer
• 13.5.Contact Us